Implantable Cardiac Output Monitor for Use After Norwood Stage ISingle Ventricle Palliation

Information

  • Research Project
  • 9555410
  • ApplicationId
    9555410
  • Core Project Number
    R43HL142383
  • Full Project Number
    1R43HL142383-01
  • Serial Number
    142383
  • FOA Number
    PA-17-302
  • Sub Project Id
  • Project Start Date
    4/16/2018 - 6 years ago
  • Project End Date
    4/15/2019 - 5 years ago
  • Program Officer Name
    EVANS, FRANK
  • Budget Start Date
    4/16/2018 - 6 years ago
  • Budget End Date
    4/15/2019 - 5 years ago
  • Fiscal Year
    2018
  • Support Year
    01
  • Suffix
  • Award Notice Date
    4/11/2018 - 6 years ago
Organizations

Implantable Cardiac Output Monitor for Use After Norwood Stage ISingle Ventricle Palliation

7. PROJECT SUMMARY/ABSTRACT For infants born with a single ventricle heart, the Norwood Stage I operation is a life-saving procedure. This procedure is the first in a three-step pathway that begins to correct a newborn?s circulation by providing flow to both the systemic circulation and pulmonary circulation from the one ventricle. After the surgery however, there is no way to continually monitor the flow that is going to the pulmonary and systemic circulations (cardiac output) to be sure each has adequate flow. The long term objective of this project is to provide the first implantable wireless blood flow monitor for patients after Norwood Stage I Single Ventricle Palliation surgery. The perivascular sensor used for measuring flow/cardiac output will be placed on the right ventricle-pulmonary artery shunt that is created during the surgery. Unlike existing technology, this will be able to provide continuous measurements to identify changes in cardiac output after surgery. This will allow for timely therapy for the patient. Additionally intermittent measurements using an injection of saline with provide information regarding the distribution of blood flow in the heart. Based on preliminary work and the prototype algorithms, this project will begin by developing a sensor system capable of transmitting and recording changes in the ultrasound velocity of blood. The meter component of the system will be made to receive these changes and programmed to automatically produce and display the flow measurements. Animal studies will then be performed on 6 piglets at the Animal Research Facility at Children?s National Medical Center in order to validate the Qp/Qs calculations in a single ventricle animal model. Phase I will end with a preliminary clinical study at Children?s National Medical Center. 4-6 patients will be recruited for a feasibility test of the sensor placement and dilution calculations.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R43
  • Administering IC
    HL
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    378509
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    837
  • Ed Inst. Type
  • Funding ICs
    NHLBI:378509\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    TRANSONIC SYSTEMS, INC.
  • Organization Department
  • Organization DUNS
    101317451
  • Organization City
    ITHACA
  • Organization State
    NY
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    148509785
  • Organization District
    UNITED STATES